Package 63187-819-30

{"route": ["ORAL"], "spl_id": "a35c75a3-e0fd-4031-8f4c-b350cac13875", "openfda": {"upc": ["0363187819309"], "unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["9e2d9c1e-a1de-491d-8f64-34ae60419611"], "manufacturer_name": ["Proficient Rx LP"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-819-30)", "package_ndc": "63187-819-30", "marketing_start_date": "20170201"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-819-60)", "package_ndc": "63187-819-60", "marketing_start_date": "20170201"}, {"sample": false, "description": "180 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-819-78)", "package_ndc": "63187-819-78", "marketing_start_date": "20170201"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-819-90)", "package_ndc": "63187-819-90", "marketing_start_date": "20170201"}], "brand_name": "Bupropion Hydrochloride", "product_id": "63187-819_a35c75a3-e0fd-4031-8f4c-b350cac13875", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "63187-819", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Proficient Rx LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA077285", "marketing_category": "ANDA", "marketing_start_date": "20150217", "listing_expiration_date": "20261231"}